Machine Learning in Melanoma Diagnosis. Limitations About to be Overcome.

Uso del aprendizaje automático en el diagnóstico del melanoma. Limitaciones por superar.
Aprendizaje automático Artificial Intelligence Clasificación de imágenes Convolutional neural networks Cáncer de piel Dermatoscopia Dermoscopy Image classification Inteligencia artificial Machine learning Melanoma Redes neuronales convolucionales Skin cancer

Journal

Actas dermo-sifiliograficas
ISSN: 2173-5778
Titre abrégé: Actas Dermosifiliogr (Engl Ed)
Pays: Spain
ID NLM: 101777537

Informations de publication

Date de publication:
May 2020
Historique:
received: 11 08 2019
accepted: 16 09 2019
pubmed: 7 4 2020
medline: 25 6 2021
entrez: 7 4 2020
Statut: ppublish

Résumé

Automated image classification is a promising branch of machine learning (ML) useful for skin cancer diagnosis, but little has been determined about its limitations for general usability in current clinical practice. To determine limitations in the selection of skin cancer images for ML analysis, particularly in melanoma. Retrospective cohort study design, including 2,849 consecutive high-quality dermoscopy images of skin tumors from 2010 to 2014, for evaluation by a ML system. Each dermoscopy image was assorted according to its eligibility for ML analysis. Of the 2,849 images chosen from our database, 968 (34%) met the inclusion criteria for analysis by the ML system. Only 64.7% of nevi and 36.6% of melanoma met the inclusion criteria. Of the 528 melanomas, 335 (63.4%) were excluded. An absence of normal surrounding skin (40.5% of all melanomas from our database) and absence of pigmentation (14.2%) were the most common reasons for exclusion from ML analysis. Only 36.6% of our melanomas were admissible for analysis by state-of-the-art ML systems. We conclude that future ML systems should be trained on larger datasets which include relevant non-ideal images from lesions evaluated in real clinical practice. Fortunately, many of these limitations are being overcome by the scientific community as recent works show.

Sections du résumé

BACKGROUND BACKGROUND
Automated image classification is a promising branch of machine learning (ML) useful for skin cancer diagnosis, but little has been determined about its limitations for general usability in current clinical practice.
OBJECTIVE OBJECTIVE
To determine limitations in the selection of skin cancer images for ML analysis, particularly in melanoma.
METHODS METHODS
Retrospective cohort study design, including 2,849 consecutive high-quality dermoscopy images of skin tumors from 2010 to 2014, for evaluation by a ML system. Each dermoscopy image was assorted according to its eligibility for ML analysis.
RESULTS RESULTS
Of the 2,849 images chosen from our database, 968 (34%) met the inclusion criteria for analysis by the ML system. Only 64.7% of nevi and 36.6% of melanoma met the inclusion criteria. Of the 528 melanomas, 335 (63.4%) were excluded. An absence of normal surrounding skin (40.5% of all melanomas from our database) and absence of pigmentation (14.2%) were the most common reasons for exclusion from ML analysis.
DISCUSSION CONCLUSIONS
Only 36.6% of our melanomas were admissible for analysis by state-of-the-art ML systems. We conclude that future ML systems should be trained on larger datasets which include relevant non-ideal images from lesions evaluated in real clinical practice. Fortunately, many of these limitations are being overcome by the scientific community as recent works show.

Identifiants

pubmed: 32248945
pii: S0001-7310(20)30004-1
doi: 10.1016/j.ad.2019.09.002
pii:
doi:

Types de publication

Journal Article

Langues

eng spa

Sous-ensembles de citation

IM

Pagination

313-316

Informations de copyright

Copyright © 2020 AEDV. Publicado por Elsevier España, S.L.U. All rights reserved.

Auteurs

C González-Cruz (C)

Servicio de Dermatología, Hospital Clínic de Barcelona, Barcelona, España.

M A Jofre (MA)

Servicio de Dermatología, Hospital Clínic de Barcelona, Barcelona, España.

S Podlipnik (S)

Servicio de Dermatología, Hospital Clínic de Barcelona, Barcelona, España; Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, España.

M Combalia (M)

Servicio de Dermatología, Hospital Clínic de Barcelona, Barcelona, España.

D Gareau (D)

Laboratory of Investigative Dermatology, The Rockefeller University, Nueva York, EE. UU.

M Gamboa (M)

Servicio de Dermatología, Hospital Clínic de Barcelona, Barcelona, España.

M G Vallone (MG)

Servicio de Dermatología, Hospital Clínic de Barcelona, Barcelona, España.

Z Faride Barragán-Estudillo (Z)

Servicio de Dermatología, Hospital Clínic de Barcelona, Barcelona, España.

A L Tamez-Peña (AL)

Servicio de Dermatología, Hospital Clínic de Barcelona, Barcelona, España.

J Montoya (J)

Servicio de Dermatología, Hospital Clínic de Barcelona, Barcelona, España.

M América Jesús-Silva (M)

Servicio de Dermatología, Hospital Clínic de Barcelona, Barcelona, España.

C Carrera (C)

Servicio de Dermatología, Hospital Clínic de Barcelona, Barcelona, España; Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, España; CIBER en Enfermedades raras, Instituto de Salud Carlos III, Barcelona, España.

J Malvehy (J)

Servicio de Dermatología, Hospital Clínic de Barcelona, Barcelona, España; Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, España; CIBER en Enfermedades raras, Instituto de Salud Carlos III, Barcelona, España.

S Puig (S)

Servicio de Dermatología, Hospital Clínic de Barcelona, Barcelona, España; Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, España; CIBER en Enfermedades raras, Instituto de Salud Carlos III, Barcelona, España. Electronic address: susipuig@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH